Petros Pharmaceuticals (PTPI) Financial Statements

Petros Pharmaceuticals's market cap is currently $499.99K. The company's EPS TTM is $-90.402; its P/E ratio is ―; Petros Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.